SL Science Holding Ltd (SLBT) stock
SLBTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 18, 2026
$0.64−0.08 (-11.73%)
Close on Nov 17, 2026Market cap $356.14MP/E –Yield –
SL Science r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for SL Science
SL Science has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?